Biosimilarity and Interchangeability: Principles and Evidence: A Systematic Review.
Author | |
---|---|
Abstract |
:
The efficacy, safety and immunogenicity risk of switching between an originator biologic and a biosimilar or from one biosimilar to another are of potential concern. |
Year of Publication |
:
2018
|
Journal |
:
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
|
Date Published |
:
2018
|
ISSN Number |
:
1173-8804
|
URL |
:
https://dx.doi.org/10.1007/s40259-017-0256-z
|
DOI |
:
10.1007/s40259-017-0256-z
|
Short Title |
:
BioDrugs
|
Download citation |